Prefibrotic myelofibrosis: Is this diagnosis valid?

Lo Ann Peterson

doi:10.1182/blood-2007-10-115303

Prefibrotic myelofibrosis: Is this diagnosis valid?

Lo Ann Peterson^*

^*Corresponding author for this work

Pathology

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Abstract

Wilkins and colleagues evaluate the utility of the World Health Organization (WHO) diagnostic criteria intended to separate cases previously classified as essential thrombocythemia (ET) into 2 groups: "true ET" and "prefibrotic myelofibrosis." Focusing on bone marrow histology, the authors found substantial variation in classification of cases.

Original language	English (US)
Pages (from-to)	1-2
Number of pages	2
Journal	Blood
Volume	111
Issue number	1
DOIs	https://doi.org/10.1182/blood-2007-10-115303
State	Published - Jan 1 2008

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2007-10-115303

Cite this

@article{1e43950806674413a01eaf49a7c5439e,

title = "Prefibrotic myelofibrosis: Is this diagnosis valid?",

abstract = "Wilkins and colleagues evaluate the utility of the World Health Organization (WHO) diagnostic criteria intended to separate cases previously classified as essential thrombocythemia (ET) into 2 groups: {"}true ET{"} and {"}prefibrotic myelofibrosis.{"} Focusing on bone marrow histology, the authors found substantial variation in classification of cases.",

author = "Peterson, {Lo Ann}",

year = "2008",

month = jan,

day = "1",

doi = "10.1182/blood-2007-10-115303",

language = "English (US)",

volume = "111",

pages = "1--2",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "1",

}

TY - JOUR

T1 - Prefibrotic myelofibrosis

T2 - Is this diagnosis valid?

AU - Peterson, Lo Ann

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Wilkins and colleagues evaluate the utility of the World Health Organization (WHO) diagnostic criteria intended to separate cases previously classified as essential thrombocythemia (ET) into 2 groups: "true ET" and "prefibrotic myelofibrosis." Focusing on bone marrow histology, the authors found substantial variation in classification of cases.

AB - Wilkins and colleagues evaluate the utility of the World Health Organization (WHO) diagnostic criteria intended to separate cases previously classified as essential thrombocythemia (ET) into 2 groups: "true ET" and "prefibrotic myelofibrosis." Focusing on bone marrow histology, the authors found substantial variation in classification of cases.

UR - http://www.scopus.com/inward/record.url?scp=38049132761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38049132761&partnerID=8YFLogxK

U2 - 10.1182/blood-2007-10-115303

DO - 10.1182/blood-2007-10-115303

M3 - Comment/debate

AN - SCOPUS:38049132761

SN - 0006-4971

VL - 111

SP - 1

EP - 2

JO - Blood

JF - Blood

IS - 1

ER -

Prefibrotic myelofibrosis: Is this diagnosis valid?

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this